Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-040237
Filing Date
2025-04-28
Accepted
2025-04-28 16:30:13
Documents
1
Period of Report
2025-04-24

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2513385-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2513385-1_4seq1.xml 4 3700
  Complete submission text file 0001104659-25-040237.txt   5113
Mailing Address 377 PLANTATION STREET WORCESTER MA 01605
Business Address 377 PLANTATION STREET WORCESTER MA 01605 7816524500
MUSTANG BIO, INC. (Issuer) CIK: 0001680048 (see all company filings)

EIN.: 473828760 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10017
Business Address
Litchman Manuel MD (Reporting) CIK: 0001709485 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38191 | Film No.: 25880835